Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational study. Manzano GS, Rice DR, Klawiter EC, Matiello M, et al. Mult Scler 2022 Apr 27:13524585221092309. doi: 10.1177/13524585221092309.

Read + Share

Amedeo Smart

Independent Medical Education

Manzano GS, Rice DR, Klawiter EC, Matiello M, et al. Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational study. Mult Scler 2022 Apr 27:13524585221092309. doi: 10.1177/13524585221092309.
PMID: 35475382